Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients

PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

January 31, 2023

Study Completion Date

August 31, 2023

Conditions
Wound Infection
Interventions
BIOLOGICAL

Bacteriophage cocktail spray

Study intervention consists of a dosage-metered airless spray containing a cocktail of 14 bacteriophages at a concentration of 1.4 x 10\^8 PFU/mL for an effective dosage of 2.5 x10\^5 PFU/cm\^2 of burned area. The study intervention will be applied in conjunction with standard of care.

DRUG

Xeroform

Standard of care will consist of Xeroform primary dressing and Kenacomb topical antibiotic cream (for wounds with signs of localized infection)

All Listed Sponsors
lead

Precisio Biotix Therapeutics, Inc.

INDUSTRY

NCT04323475 - Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients | Biotech Hunter | Biotech Hunter